Deodato, Francesco
 Distribuzione geografica
Continente #
EU - Europa 5.293
NA - Nord America 4.915
AS - Asia 976
AF - Africa 57
SA - Sud America 17
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 8
Totale 11.275
Nazione #
US - Stati Uniti d'America 4.863
DE - Germania 2.241
SE - Svezia 1.073
CN - Cina 637
UA - Ucraina 496
IT - Italia 485
IE - Irlanda 269
FR - Francia 241
GB - Regno Unito 178
FI - Finlandia 138
IN - India 134
TR - Turchia 71
CA - Canada 50
CI - Costa d'Avorio 49
BE - Belgio 41
IR - Iran 32
JP - Giappone 28
RU - Federazione Russa 27
HK - Hong Kong 22
NL - Olanda 20
SG - Singapore 19
CZ - Repubblica Ceca 18
VN - Vietnam 15
ES - Italia 12
CH - Svizzera 10
RO - Romania 10
AU - Australia 8
CL - Cile 7
EG - Egitto 6
AT - Austria 5
EU - Europa 5
DK - Danimarca 4
GR - Grecia 4
BR - Brasile 3
KZ - Kazakistan 3
PE - Perù 3
PL - Polonia 3
RS - Serbia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AR - Argentina 2
EC - Ecuador 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MK - Macedonia 2
MY - Malesia 2
NO - Norvegia 2
PT - Portogallo 2
TW - Taiwan 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
BZ - Belize 1
EE - Estonia 1
ID - Indonesia 1
KW - Kuwait 1
MA - Marocco 1
MD - Moldavia 1
MU - Mauritius 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 11.275
Città #
Chandler 1.233
Ashburn 365
Jacksonville 286
Dublin 266
San Mateo 258
Nanjing 179
Wilmington 171
Dearborn 160
Boston 125
Bremen 125
Nürnberg 114
Milan 108
New York 104
Woodbridge 103
Marseille 97
Ann Arbor 96
Beijing 92
Lawrence 81
Cattolica 79
Princeton 77
Izmir 68
Nanchang 65
Fairfield 60
Houston 56
Redwood City 55
Abidjan 49
Rome 49
Helsinki 46
Seattle 46
Brussels 41
Leawood 33
University Park 33
Zhengzhou 33
Fremont 31
Augusta 30
Kunming 30
Shenyang 30
Phoenixville 29
Norwalk 28
Redmond 28
Hebei 26
Mountain View 24
Jiaxing 23
Tianjin 22
Boardman 21
Lancaster 21
North York 21
Detroit 20
Auburn Hills 19
Changsha 19
Falls Church 19
Toronto 19
Munich 18
Pune 18
Cambridge 17
Hangzhou 16
Singapore 15
Hanoi 14
Chicago 13
Los Angeles 13
Shanghai 13
Guangzhou 12
Amsterdam 11
Andover 11
Monmouth Junction 11
Ardabil 10
Edinburgh 10
Lanzhou 10
Washington 10
Berlin 9
Hefei 9
Hong Kong 8
Kish 8
Sacramento 8
Central District 7
Indiana 7
Ningbo 7
San Francisco 7
Tokyo 7
Bari 6
Bologna 6
Jinan 6
Saint Paul 6
Sergii 6
Simi Valley 6
Brno 5
Chengdu 5
Costa Mesa 5
Latina 5
London 5
Phoenix 5
Vienna 5
Atlanta 4
Cairo 4
Duncan 4
Frankfurt am Main 4
Landshut 4
Millbury 4
Montreal 4
Mumbai 4
Totale 5.615
Nome #
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 249
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 157
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 141
Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer 138
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 135
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 132
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 131
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 130
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 128
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 127
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 125
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 124
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 122
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 122
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 121
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 121
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 120
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 119
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 118
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 118
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 118
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 118
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 117
Endocavitary in vivo dosimetry for IMRT treatments of gynecologic tumors 116
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 115
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 113
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 110
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 108
Eccrine Syringofibroadenoma radiation treatment of an unusual presentation 106
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 104
In Vivo Portal Dosimetry by an Ionization Chamber 103
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 103
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 103
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 103
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 103
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 102
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 102
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 102
FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study 101
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 97
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients 97
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 96
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 94
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 92
Forward-planned intensity modulated radiation therapy using a cobalt source: A dosimetric study in breast cancer 92
Short-course radiotherapy in elderly patients with early stage non-melanoma skin cancer: a phase II study 92
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 89
A phase I dose-escalation study (iside-bt-1) of accelerated imrt with temozolomide in patients with glioblastoma. 89
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 89
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 89
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 87
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 86
Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases 86
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 84
Initial clinical experience with Epid-based in-vivo dosimetry for VMAT treatments of head-and-neck tumors 84
Real time transit dosimetry for the breath-hold radiotherapy technique experience 83
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 82
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 82
Complexity index (COMIX) and not type of treatment predicts undetected errors in radiotherapy planning and delivery. 79
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 79
Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1) 79
Palliative two-dimensional radiotherapy of pancreatic carcinoma: a feasibility study. 78
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: A Phase II study 78
Neoadjuvant Accelerated Concomitant Boost Radiotherapy and Multidrug Chemotherapy in Locally Advanced Rectal Cancer: A Dose-Escalation Study 78
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1). 76
Synchronous male carcinoma of the breast, exocrine pancreas, and prostate 76
Intensity-modulated extended-field chemoradiation plus simultaneous integrated boost in the pre-operative treatment of locally advanced cervical cancer: a dose-escalation study 76
Active Breathing Coordinator in adjuvant three-dimensional conformal radiotherapy of early stage breast cancer: a feasibility study. 74
Palliative short-course radiation therapy in rectal cancer: A phase 2 study 74
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial 73
Optimal beam margins in linac-based VMAT stereotactic ablative body radiotherapy: A Pareto front analysis for liver metastases 72
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 72
Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study 70
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 70
18 F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study 69
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 68
Volumetric modulated arc therapy (VMAT) and simultaneous integrated boost in head-and-neck cancer: Is there a place for critical swallowing structures dose sparing? 66
Linac-based extracranial radiosurgery with Elekta volumetric modulated arc therapy and an anatomy-based treatment planning system: Feasibility and initial experience 66
Videoconferencing to enhance the integration between clinical medicine and teaching: a feasibility study 65
Feasibility Study Of Moderately Accelerated Intensity-Modulated Radiotherapy Plus Concurrent Weekly Cisplatin After Induction Chemotherapy In Locally Advanced Head-And Neck Cancer. 64
Daily on-line set-up correction in 3D-conformal radiotherapy: is it feasible? 64
Individually optimized stereotactic radiotherapy for pancreatic head tumors: A planning feasibility study 64
Cervical cancer patterns of care in Italy: A radiation oncology survey of MITO and AIRO GYN groups 64
A phase I dose-escalation study (ISIDE-BT-1) of accelerated IMRT with temozolomide in patients with glioblastoma. 63
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 63
Progestin-releasing intrauterine device insertion plus palliative radiotherapy in frail, elderly uterine cancer patients unfit for radical treatment 61
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 61
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 60
A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 60
Interventional radiotherapy as exclusive treatment for primary nasal vestibule cancer: Single-institution experience 59
Efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic/persistent/recurrent ovarian cancer: a prospective, multicenter phase II study (MITO-RT3/RAD) 58
Predictive Factors of Late-onset Rectal Mucosal Changes After Radiotherapy of Prostate Cancer 57
The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)-cT3 rectal cancer 57
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 56
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 56
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 56
Pain REduction with bone metastases STereotactic radiotherapy (PREST): A phase III randomized multicentric trial 55
Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival 55
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 54
Short course accelerated radiation therapy (SHARON) in palliative treatment of advanced solid cancer in older patients: A pooled analysis 54
Totale 9.194
Categoria #
all - tutte 39.759
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.759


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019277 0 0 0 0 0 0 0 0 0 82 121 74
2019/20201.548 260 105 71 49 142 146 167 53 146 95 213 101
2020/2021948 34 98 16 94 139 44 108 27 128 70 155 35
2021/20221.513 139 87 21 107 119 51 25 224 58 116 283 283
2022/20233.480 472 477 243 584 207 404 189 277 394 41 144 48
2023/20241.092 66 422 57 110 38 158 92 118 13 18 0 0
Totale 11.440